Status | Study |
Recruiting |
Study Name: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Condition: Endometrial Cancer Endometrial Carcinosarcoma Date: 2017-01-04 Interventions: Drug: Durvalumab Drug: Tremelimumab |
Not yet recruiting |
Study Name: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Condition: Carcinosarcoma, Ovarian Carcinosarcomas Date: 2016-12-01 Interventions: Drug: Trabectedin Other Name: Yondelis |
Not yet recruiting |
Study Name: microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer Condition: Prostate Carcinosarcoma Date: 2016-11-08 Interventions: Biological: High PSA levels |
Not yet recruiting |
Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Date: 2014-05-05 Interventions: Drug: Pazopanib plus Gemcitabine |
No longer available |
Study Name: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient Condition: Mullerian Mixed Tumor of Ovary Date: 2014-03-14 Interventions: Drug: ficlatuzumab humanized anti-hepatocyte growth factor (HGF) monoclonal antibody IV administration a |
Recruiting |
Study Name: Suitability of DCE-MRI for Detection of Vascular Changes After VBT Condition: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus Date: 2013-11-11 Interventions: Radiation: Radiotherapy |
Recruiting |
Study Name: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma Condition: Recurrent Endometrial Cancer Date: 2011-09-28 Interventions: Drug: Lapatinib and ixempra Ixabepilone 40 mg/m2 Lapatinib 250 mg |
Completed |
Study Name: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Condition: Stage IA Uterine Sarcoma Stage IB Uterine Sarcoma Stage IC Date: 2011-06-03 Interventions: Drug: paclitaxel Given IV |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Condition: Recurrent Uterine Corpus Sarcoma Uterine Carcinosarcoma Date: 2010-11-23 Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Active, not recruiting |
Study Name: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Condition: Recurrent Uterine Sarcoma Uterine Carcinosarcoma Date: 2010-07-22 Interventions: Drug: ixabepilone Given IV |